Filing Details
- Accession Number:
- 0001493152-21-007795
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-01 20:00:21
- Reporting Period:
- 2021-03-15
- Accepted Time:
- 2021-04-01 20:00:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
876343 | Lineage Cell Therapeutics Inc. | LCTX | Biological Products, (No Disgnostic Substances) (2836) | 943127919 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1841756 | Alexandra Hernandez | 2173 Salk Avenue, Suite 200 Carlsbad CA 92008 | Sr Director Finance/Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares, No Par Value | Acquisiton | 2021-03-30 | 6,000 | $0.69 | 6,000 | No | 4 | M | Direct | |
Common Shares, No Par Value | Disposition | 2021-03-30 | 6,000 | $2.23 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Shares | Employee Stock Option (Right to Buy) | Acquisiton | 2021-03-15 | 42,700 | $0.00 | 42,700 | $2.43 |
Common Shares | Employee Stock Option (Right to Buy) | Disposition | 2021-03-30 | 6,000 | $0.00 | 6,000 | $0.69 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
42,700 | 2031-03-15 | No | 4 | A | Direct | |
39,200 | 2030-03-17 | No | 4 | M | Direct |
Footnotes
- One quarter of the options vest on March 15, 2022 and the balance vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.
- One quarter of the options vested on March 17, 2021 and the balance vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.